29P Prognostic value of systemic inflammatory index and platelet-to-lymphocyte ratio in muscle-invasive bladder cancer patients treated with neoadjuvant chemo-immunotherapy in the AURA trial Article Swipe
Jean‐Frédéric Blanc
,
Nieves Martínez Chanzá
,
Aurélien Carnot
,
Philippe Barthélémy
,
Nuria Kotecki
,
M. Maetens
,
G. Dosin
,
Ahmad Awada
,
David Venet
,
C. Sotiriou
,
Sandrine Rorive
,
Françoise Rothé
·
YOU?
·
· 2024
· Open Access
·
· DOI: https://doi.org/10.1016/j.iotech.2024.100911
YOU?
·
· 2024
· Open Access
·
· DOI: https://doi.org/10.1016/j.iotech.2024.100911
Related Topics
Concepts
Metadata
- Type
- article
- Language
- en
- Landing Page
- https://doi.org/10.1016/j.iotech.2024.100911
- OA Status
- gold
- Related Works
- 10
- OpenAlex ID
- https://openalex.org/W4405374875
All OpenAlex metadata
Raw OpenAlex JSON
- OpenAlex ID
-
https://openalex.org/W4405374875Canonical identifier for this work in OpenAlex
- DOI
-
https://doi.org/10.1016/j.iotech.2024.100911Digital Object Identifier
- Title
-
29P Prognostic value of systemic inflammatory index and platelet-to-lymphocyte ratio in muscle-invasive bladder cancer patients treated with neoadjuvant chemo-immunotherapy in the AURA trialWork title
- Type
-
articleOpenAlex work type
- Language
-
enPrimary language
- Publication year
-
2024Year of publication
- Publication date
-
2024-12-01Full publication date if available
- Authors
-
Jean‐Frédéric Blanc, Nieves Martínez Chanzá, Aurélien Carnot, Philippe Barthélémy, Nuria Kotecki, M. Maetens, G. Dosin, Ahmad Awada, David Venet, C. Sotiriou, Sandrine Rorive, Françoise RothéList of authors in order
- Landing page
-
https://doi.org/10.1016/j.iotech.2024.100911Publisher landing page
- Open access
-
YesWhether a free full text is available
- OA status
-
goldOpen access status per OpenAlex
- OA URL
-
https://doi.org/10.1016/j.iotech.2024.100911Direct OA link when available
- Concepts
-
Medicine, Bladder cancer, Immunotherapy, Lymphocyte, Cancer, Internal medicine, Oncology, Aura, Platelet, MigraineTop concepts (fields/topics) attached by OpenAlex
- Cited by
-
0Total citation count in OpenAlex
- Related works (count)
-
10Other works algorithmically related by OpenAlex
Full payload
| id | https://openalex.org/W4405374875 |
|---|---|
| doi | https://doi.org/10.1016/j.iotech.2024.100911 |
| ids.doi | https://doi.org/10.1016/j.iotech.2024.100911 |
| ids.openalex | https://openalex.org/W4405374875 |
| fwci | 0.0 |
| type | article |
| title | 29P Prognostic value of systemic inflammatory index and platelet-to-lymphocyte ratio in muscle-invasive bladder cancer patients treated with neoadjuvant chemo-immunotherapy in the AURA trial |
| biblio.issue | |
| biblio.volume | 24 |
| biblio.last_page | 100911 |
| biblio.first_page | 100911 |
| topics[0].id | https://openalex.org/T11355 |
| topics[0].field.id | https://openalex.org/fields/27 |
| topics[0].field.display_name | Medicine |
| topics[0].score | 0.9998999834060669 |
| topics[0].domain.id | https://openalex.org/domains/4 |
| topics[0].domain.display_name | Health Sciences |
| topics[0].subfield.id | https://openalex.org/subfields/2730 |
| topics[0].subfield.display_name | Oncology |
| topics[0].display_name | Inflammatory Biomarkers in Disease Prognosis |
| topics[1].id | https://openalex.org/T10158 |
| topics[1].field.id | https://openalex.org/fields/27 |
| topics[1].field.display_name | Medicine |
| topics[1].score | 0.996999979019165 |
| topics[1].domain.id | https://openalex.org/domains/4 |
| topics[1].domain.display_name | Health Sciences |
| topics[1].subfield.id | https://openalex.org/subfields/2730 |
| topics[1].subfield.display_name | Oncology |
| topics[1].display_name | Cancer Immunotherapy and Biomarkers |
| topics[2].id | https://openalex.org/T10458 |
| topics[2].field.id | https://openalex.org/fields/27 |
| topics[2].field.display_name | Medicine |
| topics[2].score | 0.9945999979972839 |
| topics[2].domain.id | https://openalex.org/domains/4 |
| topics[2].domain.display_name | Health Sciences |
| topics[2].subfield.id | https://openalex.org/subfields/2746 |
| topics[2].subfield.display_name | Surgery |
| topics[2].display_name | Bladder and Urothelial Cancer Treatments |
| is_xpac | False |
| apc_list.value | 2750 |
| apc_list.currency | EUR |
| apc_list.value_usd | 2965 |
| apc_paid.value | 2750 |
| apc_paid.currency | EUR |
| apc_paid.value_usd | 2965 |
| concepts[0].id | https://openalex.org/C71924100 |
| concepts[0].level | 0 |
| concepts[0].score | 0.7949676513671875 |
| concepts[0].wikidata | https://www.wikidata.org/wiki/Q11190 |
| concepts[0].display_name | Medicine |
| concepts[1].id | https://openalex.org/C2780352672 |
| concepts[1].level | 3 |
| concepts[1].score | 0.7349684238433838 |
| concepts[1].wikidata | https://www.wikidata.org/wiki/Q504775 |
| concepts[1].display_name | Bladder cancer |
| concepts[2].id | https://openalex.org/C2777701055 |
| concepts[2].level | 3 |
| concepts[2].score | 0.5792205333709717 |
| concepts[2].wikidata | https://www.wikidata.org/wiki/Q1427096 |
| concepts[2].display_name | Immunotherapy |
| concepts[3].id | https://openalex.org/C2777761686 |
| concepts[3].level | 2 |
| concepts[3].score | 0.47760340571403503 |
| concepts[3].wikidata | https://www.wikidata.org/wiki/Q715347 |
| concepts[3].display_name | Lymphocyte |
| concepts[4].id | https://openalex.org/C121608353 |
| concepts[4].level | 2 |
| concepts[4].score | 0.47495579719543457 |
| concepts[4].wikidata | https://www.wikidata.org/wiki/Q12078 |
| concepts[4].display_name | Cancer |
| concepts[5].id | https://openalex.org/C126322002 |
| concepts[5].level | 1 |
| concepts[5].score | 0.4735086262226105 |
| concepts[5].wikidata | https://www.wikidata.org/wiki/Q11180 |
| concepts[5].display_name | Internal medicine |
| concepts[6].id | https://openalex.org/C143998085 |
| concepts[6].level | 1 |
| concepts[6].score | 0.46734195947647095 |
| concepts[6].wikidata | https://www.wikidata.org/wiki/Q162555 |
| concepts[6].display_name | Oncology |
| concepts[7].id | https://openalex.org/C2777350023 |
| concepts[7].level | 3 |
| concepts[7].score | 0.45650750398635864 |
| concepts[7].wikidata | https://www.wikidata.org/wiki/Q1154226 |
| concepts[7].display_name | Aura |
| concepts[8].id | https://openalex.org/C89560881 |
| concepts[8].level | 2 |
| concepts[8].score | 0.4340013861656189 |
| concepts[8].wikidata | https://www.wikidata.org/wiki/Q101026 |
| concepts[8].display_name | Platelet |
| concepts[9].id | https://openalex.org/C2778541695 |
| concepts[9].level | 2 |
| concepts[9].score | 0.0 |
| concepts[9].wikidata | https://www.wikidata.org/wiki/Q133823 |
| concepts[9].display_name | Migraine |
| keywords[0].id | https://openalex.org/keywords/medicine |
| keywords[0].score | 0.7949676513671875 |
| keywords[0].display_name | Medicine |
| keywords[1].id | https://openalex.org/keywords/bladder-cancer |
| keywords[1].score | 0.7349684238433838 |
| keywords[1].display_name | Bladder cancer |
| keywords[2].id | https://openalex.org/keywords/immunotherapy |
| keywords[2].score | 0.5792205333709717 |
| keywords[2].display_name | Immunotherapy |
| keywords[3].id | https://openalex.org/keywords/lymphocyte |
| keywords[3].score | 0.47760340571403503 |
| keywords[3].display_name | Lymphocyte |
| keywords[4].id | https://openalex.org/keywords/cancer |
| keywords[4].score | 0.47495579719543457 |
| keywords[4].display_name | Cancer |
| keywords[5].id | https://openalex.org/keywords/internal-medicine |
| keywords[5].score | 0.4735086262226105 |
| keywords[5].display_name | Internal medicine |
| keywords[6].id | https://openalex.org/keywords/oncology |
| keywords[6].score | 0.46734195947647095 |
| keywords[6].display_name | Oncology |
| keywords[7].id | https://openalex.org/keywords/aura |
| keywords[7].score | 0.45650750398635864 |
| keywords[7].display_name | Aura |
| keywords[8].id | https://openalex.org/keywords/platelet |
| keywords[8].score | 0.4340013861656189 |
| keywords[8].display_name | Platelet |
| language | en |
| locations[0].id | doi:10.1016/j.iotech.2024.100911 |
| locations[0].is_oa | True |
| locations[0].source.id | https://openalex.org/S4210240197 |
| locations[0].source.issn | 2590-0188 |
| locations[0].source.type | journal |
| locations[0].source.is_oa | True |
| locations[0].source.issn_l | 2590-0188 |
| locations[0].source.is_core | True |
| locations[0].source.is_in_doaj | True |
| locations[0].source.display_name | Immuno-Oncology Technology |
| locations[0].source.host_organization | https://openalex.org/P4310320990 |
| locations[0].source.host_organization_name | Elsevier BV |
| locations[0].source.host_organization_lineage | https://openalex.org/P4310320990 |
| locations[0].license | |
| locations[0].pdf_url | |
| locations[0].version | publishedVersion |
| locations[0].raw_type | journal-article |
| locations[0].license_id | |
| locations[0].is_accepted | True |
| locations[0].is_published | True |
| locations[0].raw_source_name | Immuno-Oncology and Technology |
| locations[0].landing_page_url | https://doi.org/10.1016/j.iotech.2024.100911 |
| indexed_in | crossref, doaj |
| authorships[0].author.id | https://openalex.org/A5082631947 |
| authorships[0].author.orcid | https://orcid.org/0000-0001-6172-9485 |
| authorships[0].author.display_name | Jean‐Frédéric Blanc |
| authorships[0].author_position | first |
| authorships[0].raw_author_name | J. Blanc |
| authorships[0].is_corresponding | False |
| authorships[1].author.id | https://openalex.org/A5103160612 |
| authorships[1].author.orcid | |
| authorships[1].author.display_name | Nieves Martínez Chanzá |
| authorships[1].author_position | middle |
| authorships[1].raw_author_name | N. Martinez Chanza |
| authorships[1].is_corresponding | False |
| authorships[2].author.id | https://openalex.org/A5057720244 |
| authorships[2].author.orcid | https://orcid.org/0000-0003-2933-4066 |
| authorships[2].author.display_name | Aurélien Carnot |
| authorships[2].author_position | middle |
| authorships[2].raw_author_name | A. Carnot |
| authorships[2].is_corresponding | False |
| authorships[3].author.id | https://openalex.org/A5030902321 |
| authorships[3].author.orcid | https://orcid.org/0000-0003-3917-0579 |
| authorships[3].author.display_name | Philippe Barthélémy |
| authorships[3].author_position | middle |
| authorships[3].raw_author_name | P. Barthelemy |
| authorships[3].is_corresponding | False |
| authorships[4].author.id | https://openalex.org/A5030523847 |
| authorships[4].author.orcid | https://orcid.org/0000-0002-7753-230X |
| authorships[4].author.display_name | Nuria Kotecki |
| authorships[4].author_position | middle |
| authorships[4].raw_author_name | N. Kotecki |
| authorships[4].is_corresponding | False |
| authorships[5].author.id | https://openalex.org/A5037761122 |
| authorships[5].author.orcid | |
| authorships[5].author.display_name | M. Maetens |
| authorships[5].author_position | middle |
| authorships[5].raw_author_name | M. Maetens |
| authorships[5].is_corresponding | False |
| authorships[6].author.id | https://openalex.org/A5028101706 |
| authorships[6].author.orcid | |
| authorships[6].author.display_name | G. Dosin |
| authorships[6].author_position | middle |
| authorships[6].raw_author_name | G. Dosin |
| authorships[6].is_corresponding | False |
| authorships[7].author.id | https://openalex.org/A5010064853 |
| authorships[7].author.orcid | |
| authorships[7].author.display_name | Ahmad Awada |
| authorships[7].author_position | middle |
| authorships[7].raw_author_name | A.H. Awada |
| authorships[7].is_corresponding | False |
| authorships[8].author.id | https://openalex.org/A5048492884 |
| authorships[8].author.orcid | https://orcid.org/0000-0001-9038-5271 |
| authorships[8].author.display_name | David Venet |
| authorships[8].author_position | middle |
| authorships[8].raw_author_name | D. Venet |
| authorships[8].is_corresponding | False |
| authorships[9].author.id | https://openalex.org/A5036447275 |
| authorships[9].author.orcid | |
| authorships[9].author.display_name | C. Sotiriou |
| authorships[9].author_position | middle |
| authorships[9].raw_author_name | C. Sotiriou |
| authorships[9].is_corresponding | False |
| authorships[10].author.id | https://openalex.org/A5016754309 |
| authorships[10].author.orcid | |
| authorships[10].author.display_name | Sandrine Rorive |
| authorships[10].author_position | middle |
| authorships[10].raw_author_name | S. Rorive |
| authorships[10].is_corresponding | False |
| authorships[11].author.id | https://openalex.org/A5044635323 |
| authorships[11].author.orcid | https://orcid.org/0009-0003-2625-5642 |
| authorships[11].author.display_name | Françoise Rothé |
| authorships[11].author_position | last |
| authorships[11].raw_author_name | F. Rothé |
| authorships[11].is_corresponding | False |
| has_content.pdf | False |
| has_content.grobid_xml | False |
| is_paratext | False |
| open_access.is_oa | True |
| open_access.oa_url | https://doi.org/10.1016/j.iotech.2024.100911 |
| open_access.oa_status | gold |
| open_access.any_repository_has_fulltext | False |
| created_date | 2025-10-10T00:00:00 |
| display_name | 29P Prognostic value of systemic inflammatory index and platelet-to-lymphocyte ratio in muscle-invasive bladder cancer patients treated with neoadjuvant chemo-immunotherapy in the AURA trial |
| has_fulltext | False |
| is_retracted | False |
| updated_date | 2025-11-06T03:46:38.306776 |
| primary_topic.id | https://openalex.org/T11355 |
| primary_topic.field.id | https://openalex.org/fields/27 |
| primary_topic.field.display_name | Medicine |
| primary_topic.score | 0.9998999834060669 |
| primary_topic.domain.id | https://openalex.org/domains/4 |
| primary_topic.domain.display_name | Health Sciences |
| primary_topic.subfield.id | https://openalex.org/subfields/2730 |
| primary_topic.subfield.display_name | Oncology |
| primary_topic.display_name | Inflammatory Biomarkers in Disease Prognosis |
| related_works | https://openalex.org/W2105598729, https://openalex.org/W2503866489, https://openalex.org/W2410129421, https://openalex.org/W3096289983, https://openalex.org/W2888647155, https://openalex.org/W1989009513, https://openalex.org/W2169315230, https://openalex.org/W2327807611, https://openalex.org/W4282823826, https://openalex.org/W2261933510 |
| cited_by_count | 0 |
| locations_count | 1 |
| best_oa_location.id | doi:10.1016/j.iotech.2024.100911 |
| best_oa_location.is_oa | True |
| best_oa_location.source.id | https://openalex.org/S4210240197 |
| best_oa_location.source.issn | 2590-0188 |
| best_oa_location.source.type | journal |
| best_oa_location.source.is_oa | True |
| best_oa_location.source.issn_l | 2590-0188 |
| best_oa_location.source.is_core | True |
| best_oa_location.source.is_in_doaj | True |
| best_oa_location.source.display_name | Immuno-Oncology Technology |
| best_oa_location.source.host_organization | https://openalex.org/P4310320990 |
| best_oa_location.source.host_organization_name | Elsevier BV |
| best_oa_location.source.host_organization_lineage | https://openalex.org/P4310320990 |
| best_oa_location.license | |
| best_oa_location.pdf_url | |
| best_oa_location.version | publishedVersion |
| best_oa_location.raw_type | journal-article |
| best_oa_location.license_id | |
| best_oa_location.is_accepted | True |
| best_oa_location.is_published | True |
| best_oa_location.raw_source_name | Immuno-Oncology and Technology |
| best_oa_location.landing_page_url | https://doi.org/10.1016/j.iotech.2024.100911 |
| primary_location.id | doi:10.1016/j.iotech.2024.100911 |
| primary_location.is_oa | True |
| primary_location.source.id | https://openalex.org/S4210240197 |
| primary_location.source.issn | 2590-0188 |
| primary_location.source.type | journal |
| primary_location.source.is_oa | True |
| primary_location.source.issn_l | 2590-0188 |
| primary_location.source.is_core | True |
| primary_location.source.is_in_doaj | True |
| primary_location.source.display_name | Immuno-Oncology Technology |
| primary_location.source.host_organization | https://openalex.org/P4310320990 |
| primary_location.source.host_organization_name | Elsevier BV |
| primary_location.source.host_organization_lineage | https://openalex.org/P4310320990 |
| primary_location.license | |
| primary_location.pdf_url | |
| primary_location.version | publishedVersion |
| primary_location.raw_type | journal-article |
| primary_location.license_id | |
| primary_location.is_accepted | True |
| primary_location.is_published | True |
| primary_location.raw_source_name | Immuno-Oncology and Technology |
| primary_location.landing_page_url | https://doi.org/10.1016/j.iotech.2024.100911 |
| publication_date | 2024-12-01 |
| publication_year | 2024 |
| referenced_works_count | 0 |
| abstract_inverted_index | |
| cited_by_percentile_year | |
| countries_distinct_count | 0 |
| institutions_distinct_count | 12 |
| sustainable_development_goals[0].id | https://metadata.un.org/sdg/3 |
| sustainable_development_goals[0].score | 0.5699999928474426 |
| sustainable_development_goals[0].display_name | Good health and well-being |
| citation_normalized_percentile.value | 0.44465359 |
| citation_normalized_percentile.is_in_top_1_percent | False |
| citation_normalized_percentile.is_in_top_10_percent | False |